Mirae Asset Global Investments’s Verve Therapeutics VERV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$38.7K Buy
3,444
+473
+16% +$5.31K ﹤0.01% 1298
2025
Q1
$15.5K Buy
2,971
+150
+5% +$783 ﹤0.01% 1416
2024
Q4
$17K Sell
2,821
-240
-8% -$1.45K ﹤0.01% 1442
2024
Q3
$15.2K Buy
3,061
+554
+22% +$2.76K ﹤0.01% 1467
2024
Q2
$11.9K Sell
2,507
-169,288
-99% -$806K ﹤0.01% 1444
2024
Q1
$2.45M Buy
171,795
+59,034
+52% +$841K 0.01% 1099
2023
Q4
$1.57M Sell
112,761
-99,343
-47% -$1.38M ﹤0.01% 1376
2023
Q3
$2.81M Buy
212,104
+17,277
+9% +$229K 0.01% 1050
2023
Q2
$3.65M Buy
194,827
+25,881
+15% +$485K 0.01% 982
2023
Q1
$2.44M Buy
168,946
+12,165
+8% +$175K 0.01% 1116
2022
Q4
$3.03M Buy
156,781
+19,982
+15% +$387K 0.01% 973
2022
Q3
$4.7M Buy
136,799
+19,101
+16% +$656K 0.01% 822
2022
Q2
$1.8M Buy
+117,698
New +$1.8M ﹤0.01% 1173